Get started
Author

DA Richards

Observed names: D A Richards, D.L. Richards
Observed institutions: University College Hospital, Beth Israel Deaconess Medical Center, Mayo Clinic, Memorial Sloan Kettering Cancer Center, Universitat de València, Eli Lilly (United States), University of Novi Sad, Genentech, Baylor University Medical Center, Moffitt Cancer Center, University of Chicago Medical Center, Virginia Oncology Associates, Oncology Institute of Vojvodina, Highlands Oncology Group, Dana-Farber Cancer Institute, Virginia Cancer Specialists, Vall d'Hebron Hospital Universitari, University of Pittsburgh Medical Center, The US Oncology Network, INCLIVA Health Research Institute, Arizona Oncology, Comprehensive Cancer Centers of Nevada, Vall d'Hebron Institute of Oncology, Moores Cancer Center, Winship Cancer Institute, UNC Lineberger Comprehensive Cancer Center, University of Virginia
OpenAlex ID: A5112484257
Assessment of alpha‐ and beta‐adrenoceptor blocking actions of labetalol.
1976 · DA Richards, J Tuckman, et al. · British Journal of Clinical Pharmacology · 104
PDF
Pharmacological effects of labetalol in man.
1976 · D A Richards · PubMed · 79
Double-blind trial of labetalol.
1976 · J Kane, I Gregg, et al. · PubMed · 47
Effects of H1‐ and H2‐receptor blocking agents on histamine‐induced bronchoconstriction in non‐asthmatic subjects.
1979 · JG Maconochie, EP Woodings, et al. · British Journal of Clinical Pharmacology · 40
PDF
Circulatory and alpha‐adrenoceptor blocking effects of phentolamine.
1978 · DA Richards, EP Woodings, et al. · British Journal of Clinical Pharmacology · 35
PDF
Effects of labetalol and propranolol on histamine‐induced bronchoconstriction in normal subjects.
1977 · JG Maconochie, EP Woodings, et al. · British Journal of Clinical Pharmacology · 33
PDF
Blood pressure reduction by incremental infusion of labetalol in patients with severe hypertension.
1979 · AM Cummings, JJ Brown, et al. · British Journal of Clinical Pharmacology · 25
PDF
Comparison of the effects of labetalol and propranolol in healthy men at rest and during exercise.
1977 · DA Richards, EP Woodings, et al. · British Journal of Clinical Pharmacology · 25
PDF
Circulatory effects of noradrenaline and adrenaline before and after labetalol.
1979 · DA Richards, BN Prichard, et al. · British Journal of Clinical Pharmacology · 23
PDF
Comparison of labetalol with other anti‐hypertensive drugs.
1982 · BN Prichard, DA Richards · British Journal of Clinical Pharmacology · 16
PDF
Proceedings of the Second Symposium on Labetalol, London, March 1979.
1979 · BN Prichard, DA Richards · British Journal of Clinical Pharmacology · 12
PDF
Labetalol, an alpha‐ and beta‐adrenoceptor‐blocking agent: its use in therapeutics. A summary of the symposium.
1979 · BN Prichard, DA Richards · British Journal of Clinical Pharmacology · 11
PDF
Rate of onset of hypotensive response with oral labetalol [proceedings]
1977 · AM Breckenridge, CM Macnee, et al. · British Journal of Clinical Pharmacology · 10
PDF
Abstract P4-13-25: Abemaciclib, an inhibitor of CDK4 and CDK6, combined with endocrine and HER2-targeted therapies for women with metastatic breast cancer
2016 · MP Goetz, M Beeram, et al. · Cancer Research · 6
Evaluation of a community health worker training program on hypertension and diabetes in Limpopo Province South Africa: Retention of knowledge and application within the community one year later
2015 · D.L. Richards, C. Campbell, et al. · Annals of Global Health · 3
Abstract P6-12-01: Phase II study of taselisib (GDC-0032) plus fulvestrant in HER2-negative, hormone receptor-positive advanced breast cancer: Analysis by PIK3CA and ESR1 mutation status from circulating tumor DNA
2017 · MN Dickler, C Saura, et al. · Cancer Research · 2
Abstract PD1-01: Trilaciclib (T), a CDK4/6 inhibitor, dosed with gemcitabine (G), carboplatin (C) in metastatic triple negative breast cancer (mTNBC) patients: Preliminary phase 2 results
2019 · J O'Shaughnessy, GS Wright, et al. · Cancer Research · 1
Abstract P6-12-15: Efficacy results of a phase 1/2 study of glucocorticoid receptor (GR) antagonist mifepristone (MIFE) in combination with eribulin in GR-positive triple-negative breast cancer (TNBC)
2017 · HS Han, S Wilks, et al. · Cancer Research · 1
Sympathomimetic amine infusion after beta-adrenoceptor and parasympathetic blockade [proceedings].
1979 · D A Richards, B N Prichard, et al. · PubMed · 1
The Development of Novel Thiomaleimide Photochemical Transformations and Their Application to the Manipulation of Proteins
2016 · DA Richards · UCL Discovery (University College London)
The ubuntu spirit of motivational interviewing: A pilot curriculum for community health workers in Limpopo, SA
2015 · D.L. Richards, K. Layne, et al. · Annals of Global Health
On the role of arachidoic acid in long term potentation.
1998 · DA Richards · Europe PMC (PubMed Central)
Potassium/argon dating
1991 · DA Richards, PL Smart · Bristol Research (University of Bristol)
Works count: 23
Citation count: 474
H-index: 11
I10-index: 13
Year
Topic
Type